Humira 40 MG/ 0.8 ML Pre-Filled Syringe


Combined with:

Folic Acid
Methotrexate
Prednisone

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 51.3%
Rheumatoid Arthritis 18.6%
Crohn's Disease 6.8%
Psoriasis 5.1%
Psoriatic Arthropathy 4.2%
Hypertension 2.3%
Ankylosing Spondylitis 1.8%
Vitamin Supplementation 1.5%
Pain 1.3%
Colitis Ulcerative 0.9%
Depression 0.7%
Juvenile Idiopathic Arthritis 0.7%
Diabetes Mellitus 0.7%
Asthma 0.6%
Gastrooesophageal Reflux Disease 0.6%
Anxiety 0.6%
Drug Use For Unknown Indication 0.5%
Prophylaxis 0.5%
Blood Cholesterol Increased 0.5%
Hypothyroidism 0.5%
Injection Site Pain 13.5%
Drug Ineffective 10.6%
Psoriasis 8.2%
Pain 6.4%
Rash 6.2%
Nasopharyngitis 5.6%
Sinusitis 5.4%
Malaise 4.7%
Rheumatoid Arthritis 4.5%
Pain In Extremity 3.8%
Unevaluable Event 3.8%
Fatigue 3.8%
Vomiting 3.7%
Pyrexia 3.5%
Off Label Use 3.2%
Urinary Tract Infection 2.8%
Paraesthesia 2.6%
Nausea 2.5%
Urticaria 2.5%
Weight Decreased 2.5%
Secondary
Product Used For Unknown Indication 40.8%
Rheumatoid Arthritis 15.6%
Crohn's Disease 12.4%
Psoriasis 6.0%
Psoriatic Arthropathy 5.2%
Hypertension 3.3%
Ankylosing Spondylitis 2.2%
Pain 2.0%
Vitamin Supplementation 1.9%
Colitis Ulcerative 1.6%
Anxiety 1.1%
Gastrooesophageal Reflux Disease 1.1%
Asthma 1.0%
Hypothyroidism 1.0%
Depression 0.9%
Diabetes Mellitus 0.9%
Blood Cholesterol Increased 0.8%
Hypersensitivity 0.8%
Arthritis 0.8%
Juvenile Idiopathic Arthritis 0.8%
Injection Site Pain 12.0%
Psoriasis 9.6%
Pain 7.1%
Pyrexia 6.8%
Rheumatoid Arthritis 6.6%
Vomiting 6.0%
Urinary Tract Infection 5.7%
Off Label Use 5.5%
Sinusitis 5.5%
Weight Increased 4.6%
Weight Decreased 3.8%
Drug Ineffective 3.3%
Malaise 3.3%
Nasopharyngitis 3.3%
Rash 3.3%
Wrong Technique In Drug Usage Process 3.3%
Crohn's Disease 3.0%
Injection Site Reaction 2.5%
Pain In Extremity 2.5%
Pneumonia 2.5%

Drug Data